News about ETF

Motilal Oswal analyst Manav Modi says gold is seeing a range-bound bias, having fallen sharply from a September high of around Rs 163,000–165,000 and now consolidating near Rs 148,000. Immediate support is at Rs 147,500, then Rs 146,000–145,500, while resistance sits at Rs 148,800–149,000 and then Rs 150,000–150,500. Gold trades near $4,175 with a resilient tone, supported by ETF inflows of around 187 tonnes in August and September, Chinese demand, and central-bank buying estimated at 250–300 tonnes in Q3, though elevated real yields remain the main near-term headwind. Investors are watching the upcoming Fed meeting and PCE inflation data, as cautious comments from Fed Chair Kevin Warsh have cut expectations for an October hike below 20%.

According to SoSoValue data, US spot Bitcoin and Ether ETFs recorded net outflows of $549 million last week, with Bitcoin ETFs losing $229 million and Ether funds $320 million. It was a second straight weekly outflow for Bitcoin ETFs and a third for Ether funds, though the pace slowed from the previous week's $1.22 billion. Spot Ether ETFs have seen roughly $955 million in net outflows in October so far, more than in any other month this year. Ether fell 5% over seven days to about $2,433 and Bitcoin dipped 1.3% to $82,783, per CoinGecko. Even so, both fund groups remain positive for 2026 year-to-date, with Bitcoin ETFs at about $259 million and Ether ETFs at about $610 million in net inflows.

BlackRock's crypto funds drew a net $7.9 billion of inflows in Q3, reversing $2.2 billion of outflows in the first half of 2026. Its digital asset holdings rose 63% to $79.6 billion by end-September from $48.8 billion at end-June, with $22.9 billion of the $30.8 billion gain coming from price increases. Still, assets remain 23% below the nearly $104 billion a year earlier, as market value losses of $30.6 billion over 12 months outweighed $6.3 billion of net inflows. CoinShares data show institutions held about 264,000 BTC through US spot bitcoin ETFs at end-Q2, up 1.3% from the prior quarter. The article notes that ETF ownership does not always signal long-term bets, as some positions may serve hedging or client asset management.

To collect $4,950 a month (about $59,400 a year), the capital needed depends on yield: a conservative 3.5% portfolio requires $1.7 million, while a 12% yield needs only $495,000. The article splits the target across three monthly payers: JEPQ (yield about 11.6%, roughly $171,000), O (about 5.8%, roughly $341,000) and MAIN (about 8.0% including supplementals, roughly $246,000), for a total of about $758,000. JEPQ's monthly payout ranged from $0.47 to $0.70 in 2026, with the latest at $0.57, and the fund gives up some gains in strong rallies; Realty Income just raised its quarterly dividend for the 115th consecutive time. The article also notes most income is taxed at ordinary income rates, so holding these in an IRA may help, and excluding Main Street's supplementals at a regular yield of about 5.9% would require about $336,000 for that piece.

One month after FTSE Russell upgraded Vietnam to secondary emerging market status, foreign investors net sold on 19 of 20 sessions, with only one net-buy session worth VND 54 billion. Cumulative net selling since Sept. 21 is about VND 24,800 billion (~US$1 billion), and year-to-date it exceeds VND 116,000 billion, close to the 2025 record of VND 125,000 billion. Selling pressure has spread to FPT and PNJ, whose foreign ownership has fallen below 28% and 27%, respectively. Major foreign ETFs are also failing to attract inflows, and Fubon Vietnam ETF has seen net outflows of over TWD 4 billion (more than VND 3,000 billion) since the start of the year. The VN-Index has fallen nearly 110 points (-6%) to around 1,700, amid high interest rates, thinner domestic liquidity and external pressures.

U.S. spot Bitcoin ETFs recorded net outflows of $228.6 million this week, following $681.1 million the week before, according to SoSoValue. Outflows exceeded inflows on three of five trading days, with Wednesday's $261.4 million redemption the worst session, coinciding with a hotter-than-expected September CPI reading of 3.7%. A hot producer price figure followed, reviving bets on further Federal Reserve rate hikes, and Bitcoin briefly fell below $80,000 as nearly $950 million in leveraged crypto positions were liquidated. Nexo analyst Iliya Kalchev said the drop pushed Bitcoin below the average ETF holder's cost basis near $82,300. The funds are down about $615 million for October, though cumulative net inflows since launch remain $57.3 billion.

On October 16, Bloomberg Intelligence's Mike McGlone said Bitcoin could fall toward $10,000 if US stocks drop 20% amid tighter central bank policy, a target he has repeated throughout 2026. Bitcoin trades near $82,000 as of October 18, about 35% below its all-time high of roughly $126,080 set in early October 2025. CryptoQuant founder Ki Young Ju argued that spot ETFs have absorbed $58 billion and treasury companies hold 1.3 million BTC, and that on-chain cost basis points to a floor near $30,000; a $10,000 price would imply an MVRV ratio of 0.2, below the worst historical bottom of 0.6. Technical analyst Michaël van de Poppe called the chart “not bad at all” and believes the next move is more likely to be upward.

According to DeFiLlama, Solana holds $15.5 billion in U.S. dollar stablecoins as of October 17, 2026, while Ethereum has about $143.9 billion, roughly 9.3 times larger. Yet SOL fell 6.5% over the past week to $103, and U.S. spot Solana ETFs have recorded net outflows in every session since October 5, totaling $54.9 million through October 16. The article argues stablecoin balances do not directly indicate SOL demand, since parked dollars, concentrated holdings and minimal network fees make the link weak. Solana ETF net assets fell from $1.96 billion on September 25 to $1.62 billion by October 16, though total net inflows still stand at $1.56 billion. The Alpenglow upgrade, scheduled for mainnet activation on October 21, aims to cut transaction finality from 12.8 seconds to about 150 milliseconds, but traders may already have priced it in.

The Vanguard Information Technology ETF (VGT) is a passive index fund holding 318 technology stocks. Nvidia, Apple, Microsoft and Broadcom together made up about 49% of the fund's assets as of Sept. 30. The fund has averaged 15.03% annual returns since its January 2004 inception, with 24.7% over 10 years, 20.9% over five years, 35% over three years and 35.2% over the past year. VGT does not hold Alphabet, Amazon, Meta or Tesla because they are not classified as information technology under its benchmark. The article notes that investors worried about this concentration could instead buy an S&P 500 or Nasdaq-100 ETF for broader diversification.

Covered call ETFs, which hold stocks and sell call options to generate regular income, have attracted investors seeking monthly cash flow, but they can create tax surprises. Their distributions may include ordinary dividends, capital gains and return of capital, and return of capital reduces cost basis, so tax is deferred until shares are sold, often leaving a higher capital gains tax bill later. Advisers quoted in the article warn that after-tax returns may fall short of expectations and that investors often discover the tax impact only at tax time, so holding these funds in tax-deferred accounts such as a traditional IRA is suggested. The article also points to the Morningstar Tax Cost Ratio, which measures how much taxes on distributions reduce a fund's annualized return.

Nasdaq Inc. added Moderna to its Nasdaq-100 index earlier this month; the index tracks the 100 largest non-financial companies listed on the Nasdaq. The move does not change the company's financial performance, but it raises visibility and prompts ETFs that mirror the index, such as Invesco QQQ Trust, to buy the stock. Invesco's ETF alone holds about $2 billion of Moderna, more than 2% of the $94 billion company, and roughly 80% of outstanding shares are now institutionally owned. The article argues this leaves fewer shares for individual investors, making the stock harder and more expensive for them to buy. It says the bigger driver remains the potential of Moderna's cancer vaccine intismeran autogene, combined with Merck's Keytruda, alongside COVID-19 and flu vaccine approvals, which contributed to the stock's 700% gain this year.

Ark Invest founder Cathie Wood holds $379.1 million of CRISPR Therapeutics shares and bought $1.1 million on Oct. 9 and $2.3 million on Oct. 12 through the ARK Genomic Revolution ETF, even though the stock is down more than 25% over the past year. CRISPR's only approved therapy, Casgevy, posted $76 million in Q2 revenue, up 151% year over year, but its $2.2 million list price and the 60% revenue share going to Vertex limit its economics. The company's net loss narrowed to $91.2 million from $208.5 million, and it holds $2.36 billion in cash. The article also points to CTX-310, which cut LDL cholesterol by 53% and triglycerides by 48% after 12 months in a phase 1a trial, and to a phase 2 readout for blood thinner CTX611 expected later this year.